Compare Bakrieland Development Tbk. (ELTY) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bakrieland Development Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp35 (market cap 1.52T, 58.45M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bakrieland Development Tbk. is far larger — about 14.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ELTY | SCPI | |
|---|---|---|
Market Cap | 1.52T | 104.4B |
Volume | 58.45M | — |
Lot | 584.46K | — |
Turnover | 2.03B | — |
Average Price | 34.68 | — |
Value | 2.03B | — |
Indicative Equilibrium Price | 35 | — |
Indicative Equilibrium Volume | 99.73K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bakrieland Development Tbk.
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
